Named after the hundred-eyed watchman of Greek myth, Argus watches the education landscape: spotting new opportunities, pressure-testing the ventures we're building, and tracing every read back to the real-world signals behind it.
The evidence library: the raw signals the pipeline is watching across the education ecosystem. Every idea is built from these.
Candid’s Series D round was led by Sixth Street Growth, with participation from Oak HC/FT, 8VC and Y Combinator. The post Candid Health Snags $120M for AI RCM Platform appeared first on MedCity News .
VBC aligns reimbursements to outcomes, emphasizing the quality and effectiveness, not quantity, of healthcare activities. But the same cost constraints driving interest in VBC can also turn it into a liability. The post Why Value-Based Care Only Works If You’ve Tamed Costs appeared first on MedCity News .
A core principle of trauma-informed care is understanding that past and ongoing exposure to stress and trauma can directly shape health outcomes. But by remaining blind to these histories, the medical community severely limits its ability to address the very drivers of the diseases it is trying to cure. The post Medicine Understands Trauma’s Impact, But Rarely Asks About It appeared first on MedCity News .
A new paper shows Cleveland Clinic’s AI scribe rollout is paying dividends in clinician satisfaction and retention. These are key metrics for hospitals to track, given they spend millions on recruitment and retention efforts amid an ongoing workforce crisis. The post Ambient Scribes Improve Clinician Retention, Cleveland Clinic Research Shows appeared first on MedCity News .
Abcuro will apply the capital to a study that could support a biologics license application in inclusion body myositis, a rare inflammatory disorder that leads to worsening muscle weakness. A Phase 2/3 study failed earlier this year, but Abcuro saw positive trends in patients with less severe disease. The post Abcuro Adds $66M to Try Again in Rare Inflammatory Disorder With No Approved Drugs appeared first on MedCity News .
Cityblock Health plans to acquire rural healthcare provider Homeward Health and has raised $116 million to expand its value-based care model to rural and Medicare Advantage populations. The post Cityblock to Acquire Homeward Health, Secures $116M Series E appeared first on MedCity News .
But the deadline that most people are not tracking, and the most worrisome, is October 1, 2026. It’s the day federal Medicaid funding ends for the country’s most vulnerable populations, including refugees, asylees, and humanitarian parolees. The post How to Prepare Your Hospital Before H.R. 1 Hits in 2027 appeared first on MedCity News .
Merck’s Lipfendra is the first FDA-approved pill in the class of cholesterol-lowering drugs called PCSK9 inhibitors. While peptides are typically injected, Lipfendra is a macrocyclic peptide designed for formulation as an oral drug. The post Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs appeared first on MedCity News .
What should life sciences investors and targets focus on for dealmaking success? Here are six actionable steps. The post Hybrid Financing in Life Sciences: Unlocking Growth Amid Market Challenges appeared first on MedCity News .
Here’s what healthcare entities should know about the maturing landscape, what to actually be concerned about, and the next stage of healthcare data evolution as we know it. The post Are We Entering an Interoperability Trust Recession? appeared first on MedCity News .
Women’s health startups should plan for reimbursement early, as limited research and evidence can make securing coverage difficult, a new report explains. The post The Reimbursement Challenges Hurting Women’s Health Companies, Per Milken Institute appeared first on MedCity News .
Vogenx’s mizagliflozin is heading into Phase 2b testing for post-bariatric hypoglycemia (PBH). Amylyx Pharmaceuticals and Recordati are developing injectable peptide drugs for this metabolic disorder, but Vogenx aims to stand apart by offering patients a different mechanism of action and oral dosing. The post Vogenx IPO Raises $81M for Trial in Metabolic Disease With No Approved Drugs appeared first on MedCity News .
The bottleneck in AI-enabled real-world data analysis is not computation, model architecture, or training data volume. It is the semantic layer over which the AI is trying to reason – the place where precise clinical meaning lives. The post Better Models Won’t Fix Pharma’s AI Problem — Better Terminology Will appeared first on MedCity News .
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is that not only is this terrible for patient health, it can be more costly in the end. The post The True Cost of Focusing on Cost Instead of Cost-Effectiveness appeared first on MedCity News .
Latigo Biotherapeutics will apply the IPO proceeds toward a pipeline that includes a next-generation non-opioid pain drug ready for pivotal testing. BlossomHill Therapeutics also debuted on the Nasdaq, raising cash for cancer drugs designed to address mutations not covered by currently available therapies. The post Latigo Bio’s IPO Lands $346M for Pipeline of Non-Opioid Pain Drugs appeared first on MedCity News .
The problem may not be the investment. It may be the target of the intervention. The post Why Kidney Care’s Biggest Investment Wave Hasn’t Moved Hospital Costs appeared first on MedCity News .
A letter to Medicaid Directors, State Leaders, and other invested collaborators who were awarded Rural Health Transformation (RHT) Grant funding. The post My Wish For Better Care For Americans Living in Rural Areas appeared first on MedCity News .
Apnimed will apply the IPO proceeds toward the regulatory process and launch plans of Oxnimbi, a once-nightly pill developed for obstructive sleep apnea. This drug is under FDA review with a February 2027 target date for a regulatory decision. The post Apnimed’s IPO Bags $192M for What Could Become the First Oral Sleep Apnea Drug appeared first on MedCity News .
Health tech companies made several major funding announcements in July. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in July appeared first on MedCity News .
The future of value-based care will hinge on empowering providers, and specialists in particular, with the data and strategic partnerships to proactively manage patient health beyond traditional clinical settings. The post The Next Phase of Value-Based Care: Why Specialty-Led Models Will Define the Future of Healthcare appeared first on MedCity News .
Hope is a catalyst for scientific ambition. It encourages researchers, clinicians, investors, and innovators to pursue solutions where none currently exist. In oncology, many major breakthroughs begin with the belief that a better answer is possible. The post Hope Is Not a Soft Concept, It’s a Strategic Imperative in Cancer Innovation appeared first on MedCity News .
Drug spending continues to grow, but that doesn’t mean that everyone is getting the medicines that they need. A panel at MedCity News’ Bullseye event discussed the evolution of the prescription drug marketplace. The post A Prescription for Drug Costs: Inject Transparency and Improve Accessibility appeared first on MedCity News .
Health tech investors say the founders who win them over aren’t the ones with all the answers, but the ones who know exactly what they don’t know — and build a team to cover the gap. The post What Health Tech Investors Love in Founders — and What They Can’t Stand appeared first on MedCity News .
Epic faced an FTC antitrust probe this week, but that didn’t stop the EHR giant from unveiling a wave of new AI tools at its annual conference. The post This Week In Epic News: FTC Probe, AI Agents & More appeared first on MedCity News .
In this episode, we’re joined by Amanda Shafton, practicing CNM and national director of midwifery at Ob Hospitalist Group. We discuss the benefits of physician/midwifery collaboration and how midwives can improve maternal health outcomes. The post MedCity FemFwd: How Midwives Can Support the Maternal Health Crisis appeared first on MedCity News .
Health tech companies made several major funding announcements in August. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in August appeared first on MedCity News .
Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic options. Originally developed by Protagonist Therapeutics, the engineered peptide gives Takeda a drug with blockbuster sales potential as the pharma company’s top overall product faces patent expirations. The post First-in-Class Takeda, Protagonist Drug Lands FDA Approval in Rare Blood Disorder appeared first on MedCity News .
If AI is not one of the CEO’s top two or three priorities, the organization will produce pilots and slide decks while better-mobilized peers pull ahead and the institution’s ability to fulfill its mission erodes The post AI Won’t Transform Health Systems, CEOs Will — 6 Principles to Drive the Transformation appeared first on MedCity News .
Lakshmi Halasyamani, chief clinical officer at Endeavor Health, thinks value-based care isn’t really about payment models. To her, this work centers on understanding patients’ clinical, social and financial circumstances well enough to make care plans that actually work for their lives. The post Why Endeavor Health Refuses to Silo Its Value-Based Care Strategy appeared first on MedCity News .
Argenx’s first acquisition is the buyout of Forte Biosciences, a company with a lead drug that has early clinical validation in celiac disease and vitiligo. Argenx executives say this antibody complements its blockbuster product Vyvgart, offering a different mechanism of action but similar pipeline-in-a-product potential. The post Argenx’s $2B Forte Bio Acquisition Brings Autoimmune Playbook to Prevalent Disorders appeared first on MedCity News .
When staff are overextended and patients face delays or abandon care, the issue is no longer a narrow administrative burden. It becomes a business, financial, and access challenge that demands a different operating model. The post Prior Authorization Is Draining Revenue: Why Automation Has Become a Strategic Imperative appeared first on MedCity News .
The question is not whether the technology is impressive. The question is whether it shows up at the right time, with the right information, inside the workflow where the decision is being made. Anything else is just another report. The post How AI Inside Clinical Workflows Is Unlocking Patient Throughput appeared first on MedCity News .
[Sponsored] On a recent webinar sponsored by Verato, panelists from SCAN Health Group and the Alliance of Community Health Plans discussed how their organizations are meeting the moment. The post AI Readiness Starts with Solving Healthcare’s Data Fragmentation Problem appeared first on MedCity News .
As patients increasingly bring AI chatbot advice into exam rooms, where does liability land when that advice goes wrong? Health law attorney Meghan O’Connor said the answer still isn’t clear, but silence is the riskiest response for providers. The post What Happens When Patients Trust AI Over Their Doctor? appeared first on MedCity News .
A pharmacy error at an Ascension hospital in Nashville left four joint replacement patients injected with potassium phosphate instead of spinal anesthetic. The mix-up paralyzed one patient and harmed the other three. The Tennessee Bureau of Investigation is now probing the case. The post 4 Patients Injured After Drug Mix-Up at Ascension Hospital in Nashville appeared first on MedCity News .
Expressable has joined Amazon’s Health Benefits Connector to help families access virtual speech therapy through their insurance. The post Amazon Taps Expressable for Health Benefits Connector appeared first on MedCity News .
Hanmi Pharmaceutical’s drug is designed to activate a receptor in skeletal muscle to both increase muscle mass and reduce fat. This engineered peptide gives Roche a clinical-stage asset that addresses a different target than the other obesity drugs in its pipeline. The post Roche Gains Rights to Hanmi Obesity Drug That Reduces Fat, Preserves Muscle appeared first on MedCity News .
[Sponsored] Discover how payers can shift from costly post-payment recovery to intentional prevention through data-driven oversight, accountability, and partnership. The post A Partnership-driven Approach to Waste and Abuse Prevention appeared first on MedCity News .
Metabolic psychiatry has moved past being a fringe theory. It is a practical, evidence-based necessity for a field that has been stagnant for too long. The post Why Psychiatry Can’t Ignore Metabolic Health Anymore appeared first on MedCity News .
As hospitals increasingly use AI to improve patient care, the same technology is being used by hackers and nation-states to launch faster, more sophisticated attacks. Karen Habercoss, chief information security and privacy officer at the University of Chicago Medicine, explained how her health system is building a governance structure to manage that risk. The post The Same AI That Helps Patients Is Being Used to Attack Them, Hospital Exec Says appeared first on MedCity News .
A new report from the Peterson Health Technology Institute argues that today’s healthcare payment models are ill-suited for clinical AI and could drive up costs. The post How Should Clinical AI Be Paid For? 3 Takeaways appeared first on MedCity News .
Personalis’s liquid biopsy is part of a growing market for minimal residual disease assays, tests that look for any remaining cancer cells after the initial treatment. Tempus AI has been the commercial partner on this Personalis test since 2023. The post Expecting Massive Test Growth in Cancer & More, Tempus AI Strikes $1.5B Deal to Buy Personalis appeared first on MedCity News .
These three legal regimes are pulling in different directions, and the developers that navigate them well will be the ones that plan for all three from the start. The post The AI Tension in Healthcare: Patent Strategy, FDA Reality, and HIPAA Constraints appeared first on MedCity News .
Rural Health Transformation Program funding gives states broad flexibility and may help address longstanding access gaps. The post For Millions in Rural America, Medicine Is Still Far Away appeared first on MedCity News .
A new PwC report says the women’s oncology market could reach $110 billion by 2030, though funding and care gaps remain. The post Women’s Oncology Market Could Reach $110B in 2030, but Gaps Remain appeared first on MedCity News .
KFF found that insurers denied 12%-18% of standard prior authorization requests in 2025, with significant variation among insurers and gaps in transparency. The post KFF: Insurers Denied 12%-18% of Prior Authorization Requests in 2025 appeared first on MedCity News .
Migraine drugs developer Slate Medicines is going public in a reverse merger with Fulcrum Therapeutics. The biotech’s lead antibody drug blocks two novel migraine targets, offering the potential for better efficacy compared to other next-generation migraine drugs in R&D. The post Slate Medicines’ Merger and $245M Private Placement Fuel Mission in Migraine appeared first on MedCity News .
Consumer diagnostics will be one of several discussions at the INVEST Digital Health conference focused on power shifting to the consumer in healthcare. The conference is scheduled for October 29 in Dallas at Pegasus Park, in partnership with Health Wildcatters. The post The Rise of Consumer Diagnostics and Emerging Trends appeared first on MedCity News .
Most healthcare organizations are experimenting with AI. Few are preparing to manage AI agents as participants in everyday healthcare workflows. The post Healthcare Is Deploying AI Tools — It’s Not Ready for AI Colleagues appeared first on MedCity News .
[Sponsored] A recent webinar, sponsored by Verato, offered insights from executives at SCAN Health Plan and the Alliance of Community Health Plans on a wide range of tech challenges in healthcare from fragmented data to technology architecture to patient identity. The post How Payers and Health Plans Think of Identity and the Risks of Fragmented Data appeared first on MedCity News .